Literature DB >> 3155461

Immunoregulatory T cell circuits in man. Identification of a distinct T cell subpopulation of the helper/inducer lineage that amplifies the development of alloantigen-specific suppressor T cells.

N K Damle, N Mohagheghpour, G S Kansas, D M Fishwild, E G Engleman.   

Abstract

Regulation of the immune response in man is dependent on interactions between cells of helper/inducer (Leu-3+/T4+) lineage and cells of suppressor/cytotoxic (Leu-2+/T8+) lineage. By using the mixed leukocyte reaction (MLR) as a model system, we have shown previously that alloantigen-primed Leu-3+ cells induce autologous Leu-2+ cells to differentiate into suppressor T cells that specifically inhibit the response of fresh T cells to the original allogeneic stimulator cells. The current study was undertaken to analyze the roles in this suppressor circuit of subpopulations of Leu-3+ cells distinguished from one another on the basis of their binding or lack of binding to monoclonal anti-Leu-8 antibody. Although both Leu-3+,8- and Leu-3+,8+ T cells proliferated in allogeneic MLR, alloactivated Leu-3+,8+ cells alone induced proliferation and differentiation of Leu-2+ suppressor cells. Leu-3+,8+ cells also induced Leu-3+,8- cells to proliferate, and following their activation in this manner, such autoactivated Leu-3+,8- cells augmented the differentiation of Leu-2+ suppressor cells, but only in the presence of alloactivated Leu-3+,8+ cells. Furthermore, this effect, like the suppressor effect, was specific for the inducer cells, and thus indirectly for the HLA-DR antigens of the original allogeneic stimulator cells as well. These results indicate that alloantigen-primed Leu-3+,8+ cells not only activate specific Leu-2+ suppressor cells but also activate specific Leu-3+,8- suppressor-amplifier cells, and in combination, these cells exert potent feedback inhibition of MLR.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3155461

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Mechanisms in contact dermatitis.

Authors:  E A Abel; G S Wood
Journal:  Clin Rev Allergy       Date:  1986-08

2.  The remarkable proliferation of helper T cell subset in response to autologous thyrocytes and intrathyroidal T cells from patients with Graves' disease.

Authors:  K Eguchi; T Otsubo; Y Kawabe; Y Ueki; T Fukuda; M Matsunaga; C Shimomura; N Ishikawa; H Tezuka; H Nakao
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

3.  Demonstration of an indomethacin-sensitive mechanism regulating immune reactivity in American cutaneous leishmaniasis patients.

Authors:  M Castes; D Trujillo; D Scott; A J Rondon
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

4.  [The effect of rejection crises and immunosuppressive therapy on the lymphocyte subpopulations of patients after kidney transplantation].

Authors:  A v Kiparski; D Frei; W Fierz; G Frei; G Uhlschmid; F Largiader; U Binswanger
Journal:  Klin Wochenschr       Date:  1990-04-17

5.  Identification and isolation of OKT4+ suppressor cells with the monoclonal antibody WR16.

Authors:  K Moore; A M Nesbitt
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

6.  DY determinants, possibly associated with novel class II molecules, stimulate autoreactive CD4+ T cells with suppressive activity.

Authors:  G Pawelec; N Fernandez; T Brocker; E M Schneider; H Festenstein; P Wernet
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

7.  A subset of memory CD4+ helper T lymphocytes identified by expression of Pgp-1.

Authors:  K Butterfield; C G Fathman; R C Budd
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

8.  Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action.

Authors:  B M Hall; N W Pearce; K E Gurley; S E Dorsch
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.